Gami-Chunghyuldan ameliorates memory impairment and neurodegeneration induced by intrahippocampal Aβ1-42 oligomer injection

Neurobiology of Learning and Memory

Volumn 96, Issue 2, 2011, Pages 306-314

  Choi, Jin Gyu ^a   Moon, Minho ^b   Kim, Hyo Geun ^a   Mook Jung, Inhee ^b   Chung, Sun Yong ^c   Kang, Tong Ho ^a   Kim, Sun Yeou ^a   Lee, Eunjoo H ^a   Oh, Myung Sook ^a  

^a Kyung Hee University   (South Korea)

^b Seoul National University   (South Korea)

^c Kyung Hee University College of Medicine   (South Korea)

Author keywords

Alzheimer's disease; Amyloid beta oligomer; Gami Chunghyuldan; Memory impairment; Neurodegeneration

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CHINESE DRUG; GAMI CHUNGHYULDAN; PLACEBO; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; AVOIDANCE BEHAVIOR; CELL ACTIVATION; CHOLINERGIC NERVE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG RESPONSE; HERBAL MEDICINE; HIPPOCAMPUS; MALE; MEMORY DISORDER; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; SYNAPTIC TRANSMISSION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; DRUGS, CHINESE HERBAL; HIPPOCAMPUS; MALE; MEMORY; MEMORY DISORDERS; MICE; NERVE DEGENERATION; NEURONS; PEPTIDE FRAGMENTS; SYNAPSES;

EID: 79960841704     PISSN: 10747427     EISSN: 10959564     Source Type: Journal    
DOI: 10.1016/j.nlm.2011.06.004     Document Type: Article

References (73)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., et al. Inflammation and Alzheimer's disease. Neurobiology of Aging 2000, 21:383-421.
2. Balducci C., Beeg M., Stravalaci M., Bastone A., Sclip A., Biasini E., et al. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:2295-2300.
3. Chinese herbal medicine formulas and strategies 1990, Eastland Press, Seattle. D.B.R. Bansky (Ed.).
4. Bales K.R., Tzavara E.T., Wu S., Wade M.R., Bymaster F.P., Paul S.M., et al. Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody. Journal of Clinical Investigation 2006, 116:825-832.
5. Behl C., Davis J., Cole G.M., Schubert D. Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochemical and Biophysical Research Communications 1992, 186:944-950.
6. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nature Reviews Neuroscience 2007, 8:57-69.
7. Bronfman F.C., Moechars D., Van Leuven F. Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein London mutant transgenic mice. Neurobiology of Disease 2000, 7:152-168.
8. Buttini M., Yu G.Q., Shockley K., Huang Y., Jones B., Masliah E., et al. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation. Journal of Neuroscience 2002, 22:10539-10548.
9. Cancino G.I., Toledo E.M., Leal N.R., Hernandez D.E., Yevenes L.F., Inestrosa N.C., et al. STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's beta-amyloid deposits. Brain 2008, 131:2425-2442.
10. Casal S., Oliveira M.B., Alves M.R., Ferreira M.A. Discriminate analysis of roasted coffee varieties for trigonelline, nicotinic acid, and caffeine content. Journal of Agricultural and Food Chemistry 2000, 48:3420-3424.
11. Chao C.C., Hu S., Ehrlich L., Peterson P.K. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: Involvement of nitric oxide and of N-methyl-d-aspartate receptors. Brain, Behavior, and Immunity 1995, 9:355-365.
12. Cho K.H., Kang H.S., Jung W.S., Park S.U., Moon S.K. Efficacy and safety of chunghyul-dan (qingwie-dan) in patients with hypercholesterolemia. The American Journal of Chinese Medicine 2005, 33:241-248.
13. Cho K.H., Oh J.K., Jang Y.S., Jung J.W., Oh H.R., Park E.K., et al. Combination drug therapy using edaravone and Daio-Orengedoku-to after transient focal ischemia in rats. Methods and Findings in Experimental and Clinical Pharmacology 2008, 30:443-450.
14. Choi J.G., Moon M., Jeong H.U., Kim M.C., Kim S.Y., Oh M.S. Cistanches Herba enhances learning and memory by inducing nerve growth factor. Behavioural Brain Research 2011, 216:652-658.
15. Chromy B.A., Nowak R.J., Lambert M.P., Viola K.L., Chang L., Velasco P.T., et al. Self-assembly of Abeta(1-42) into globular neurotoxins. Biochemistry 2003, 42:12749-12760.
16. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nature Neuroscience 2005, 8:79-84.
17. DeKosky S.T., Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Annals of Neurology 1990, 27:457-464.
18. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993, 7:75-83.
19. Ewbank D.C. Deaths attributable to Alzheimer's disease in the United States. American Journal of Public Health 1999, 89:90-92.
20. Giovannini M.G., Scali C., Prosperi C., Bellucci A., Vannucchi M.G., Rosi S., et al. Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: Involvement of the p38MAPK pathway. Neurobiology of Disease 2002, 11:257-274.
21. Gu J.W., Hasuo H., Takeya M., Akasu T. Effects of emodin on synaptic transmission in rat hippocampal CA1 pyramidal neurons in vitro. Neuropharmacology 2005, 49:103-111.
22. Hof P.R., Giannakopoulos P., Vickers J.C., Bouras C., Morrison J.H. The morphologic and neurochemical basis of dementia: Aging, hierarchical patterns of lesion distribution and vulnerable neuronal phenotype. Reviews in the Neurosciences 1995, 6:97-124.
23. Karasawa J., Hashimoto K., Chaki S. d-serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats. Behavioural Brain Research 2008, 186:78-83.
24. Kelly R.B. Storage and release of neurotransmitters. Cell 1993, 72(Suppl.):43-53.
25. Kempermann G., Gast D., Kronenberg G., Yamaguchi M., Gage F.H. Early determination and long-term persistence of adult-generated new neurons in the hippocampus of mice. Development 2003, 130:391-399.
26. Kim H.G., Ju M.S., Kim D.H., Hong J., Cho S.H., Cho K.H., et al. Protective effects of Chunghyuldan against ROS-mediated neuronal cell death in models of Parkinson's disease. Basic and Clinical Pharmacology and Toxicology 2010, 107:958-964.
27. Kim D.S., Kim J.Y., Han Y.S. Alzheimer's disease drug discovery from herbs: Neuroprotectivity from beta-amyloid (1-42) insult. Journal of Alternative and Complementary Medicine 2007, 13:333-340.
28. Lacor P.N., Buniel M.C., Furlow P.W., Clemente A.S., Velasco P.T., Wood M., et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. Journal of Neuroscience 2007, 27:796-807.
29. LaDu M.J., Shah J.A., Reardon C.A., Getz G.S., Bu G., Hu J., et al. Apolipoprotein E receptors mediate the effects of beta-amyloid on astrocyte cultures. Journal of Biological Chemistry 2000, 275:33974-33980.
30. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:6448-6453.
31. Lee B., Choi E.J., Lee E.J., Han S.M., Hahm D.H., Lee H.J., et al. The neuroprotective effect of methanol extract of Gagamjungjihwan and fructus euodiae on ischemia-induced neuronal and cognitive impairment in the rat. Evidence Based Complementary and Alternative Medicine 2009.
32. Lee H., Kim Y.O., Kim H., Kim S.Y., Noh H.S., Kang S.S., et al. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB Journal 2003, 17:1943-1944.
33. Li Y.Y., Lu J.H., Li Q., Zhao Y.Y., Pu X.P. Pedicularioside A from Buddleia lindleyana inhibits cell death induced by 1-methyl-4-phenylpyridinium ions (MPP+) in primary cultures of rat mesencephalic neurons. European Journal of Pharmacology 2008, 579:134-140.
34. Mandel S.A., Amit T., Kalfon L., Reznichenko L., Youdim M.B. Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. Journal of Nutrition 2008, 138:1578S-1583S.
35. Mandrekar S., Jiang Q., Lee C.Y., Koenigsknecht-Talboo J., Holtzman D.M., Landreth G.E. Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. Journal of Neuroscience 2009, 29:4252-4262.
36. Mann D.M. Pyramidal nerve cell loss in Alzheimer's disease. Neurodegeneration 1996, 5:423-427.
37. Masliah E., Mallory M., Alford M., DeTeresa R., Hansen L.A., McKeel D.W., et al. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 2001, 56:127-129.
38. Minghetti L., Ajmone-Cat M.A., De Berardinis M.A., De Simone R. Microglial activation in chronic neurodegenerative diseases: Roles of apoptotic neurons and chronic stimulation. Brain Research. Brain Research Reviews 2005, 48:251-256.
39. Misiti F., Sampaolese B., Mezzogori D., Orsini F., Pezzotti M., Giardina B., et al. Protective effect of rhubarb derivatives on amyloid beta (1-42) peptide-induced apoptosis in IMR-32 cells: A case of nutrigenomic. Brain Research Bulletin 2006, 71:29-36.
40. Moon M., Choi J.G., Nam D.W., Hong H.S., Choi Y.J., Oh M.S., et al. Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-beta1-42 oligomer-injected mice. Journal of Alzheimers Disease 2010.
41. Nam K.N., Choi Y.S., Jung H.J., Park G.H., Park J.M., Moon S.K., et al. Genipin inhibits the inflammatory response of rat brain microglial cells. International Immunopharmacology 2010, 10:493-499.
42. Nam K.N., Jung H.J., Kim M.H., Kang C., Jung W.S., Cho K.H., et al. Chunghyuldan attenuates brain microglial inflammatory response. Canadian Journal of Physiology and Pharmacology 2009, 87:448-454.
43. Oh M.S., Huh Y., Bae H., Ahn D.K., Park S.K. The multi-herbal formula Guibi-tang enhances memory and increases cell proliferation in the rat hippocampus. Neuroscience Letters 2005, 379:205-208.
44. Pachter J.S. Inflammatory mechanisms in Alzheimer disease: The role of beta-amyloid/glial interactions. Molecular Psychiatry 1997, 2:91-95.
45. Paxinos, G. F. K. B. J. (Ed.) (2001). The mouse brain in stereotaxic coordinates (2nd ed.). Academic Press.
46. Pickering M., Cumiskey D., O'Connor J.J. Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Experimental Physiology 2005, 90:663-670.
47. Pinkel D. The use of body surface area as a criterion of drug dosage in cancer chemotherapy. Cancer Research 1958, 18:853-856.
48. Ragozzino M.E., Unick K.E., Gold P.E. Hippocampal acetylcholine release during memory testing in rats: Augmentation by glucose. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:4693-4698.
49. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB Journal 2008, 22:659-661.
50. Sakono M., Zako T. Amyloid oligomers: Formation and toxicity of Abeta oligomers. FEBS Journal 2010, 277:1348-1358.
51. Sato H., Ishizawa F., Hirayama H., Hishinuma T., Mizugaki M. Extra-weak chemiluminescence of drugs. XIV. Quenching effects of anthraquinones on the extra-weak chemiluminescence from lipid peroxidation in rat brain homogenates. Yakugaku Zasshi 1992, 112:199-202.
52. Scheff S.W., DeKosky S.T., Price D.A. Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiology of Aging 1990, 11:29-37.
53. Selkoe D.J. Alzheimer's disease: A central role for amyloid. Journal of Neuropathology and Experimental Neurology 1994, 53:438-447.
54. Seo J.S., Yun J.H., Baek I.S., Leem Y.H., Kang H.W., Cho H.K., et al. Oriental medicine Jangwonhwan reduces Abeta(1-42) level and beta-amyloid deposition in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease. Journal of Ethnopharmacology 2010, 128:206-212.
55. Shirayama Y., Muneoka K., Fukumoto M., Tadokoro S., Fukami G., Hashimoto K., et al. Infusions of allopregnanolone into the hippocampus and amygdala, but not into the nucleus accumbens and medial prefrontal cortex, produce antidepressant effects on the learned helplessness rats. Hippocampus 2010.
56. Squire, L. R. (Ed.) (2009). Encyclopedia of neuroscience (1st ed.). Academic Press.
57. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., et al. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Annals of Neurology 1991, 30:572-580.
58. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416:535-539.
59. Walsh D.M., Klyubin I., Fadeeva J.V., Rowan M.J., Selkoe D.J. Amyloid-beta oligomers: Their production, toxicity and therapeutic inhibition. Biochemical Society Transactions 2002, 30:552-557.
60. Wang H.W., Pasternak J.F., Kuo H., Ristic H., Lambert M.P., Chromy B., et al. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Research 2002, 924:133-140.
61. Wang H., Xu Y., Yan J., Zhao X., Sun X., Zhang Y., et al. Acteoside protects human neuroblastoma SH-SY5Y cells against beta-amyloid-induced cell injury. Brain Research 2009, 1283:139-147.
62. Weinreb O., Mandel S., Bar-Am O., Yogev-Falach M., Avramovich-Tirosh Y., Amit T., et al. Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs. Neurotherapeutics 2009, 6:163-174.
63. West M.J., Coleman P.D., Flood D.G., Troncoso J.C. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 1994, 344:769-772.
64. White J.A., Manelli A.M., Holmberg K.H., Van Eldik L.J., Ladu M.J. Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation. Neurobiology of Disease 2005, 18:459-465.
65. Wyss-Coray T., Loike J.D., Brionne T.C., Lu E., Anankov R., Yan F., et al. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nature Medicine 2003, 9:453-457.
66. Yamazaki M., Sakura N., Chiba K., Mohri T. Prevention of the neurotoxicity of the amyloid beta protein by genipin. Biological and Pharmaceutical Bulletin 2001, 24:1454-1455.
67. Yan M., Zhang L.Y., Sun L.X., Jiang Z.Z., Xiao X.H. Nephrotoxicity study of total rhubarb anthraquinones on Sprague Dawley rats using DNA microarrays. Journal of Ethnopharmacology 2006, 107:308-311.
68. Yao Z., Drieu K., Papadopoulos V. The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligands. Brain Research 2001, 889:181-190.
69. Youdim M.B., Buccafusco J.J. CNS targets for multi-functional drugs in the treatment of Alzheimer's and Parkinson's diseases. Journal of Neural Transmission 2005, 112:519-537.
70. Youdim M.B., Buccafusco J.J. Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders. Trends in Pharmacological Sciences 2005, 26:27-35.
71. Yu Y.B., Dosanjh L., Lao L., Tan M., Shim B.S., Luo Y. Cinnamomum cassia bark in two herbal formulas increases life span in Caenorhabditis elegans via insulin signaling and stress response pathways. PLoS ONE 2010, 5:e9339.
72. Zhang Y., Wang X., Xu Z., Liu Z., Ni Q., Chu X., et al. Protective effect of flavonoids from Scutellaria baicalensis Georgi on cerebral ischemia injury. Journal of Ethnopharmacology 2006, 108:355-360.
73. Zhao J., Jiang P., Zhang W. Molecular networks for the study of TCM pharmacology. Briefings in Bioinformatics 2009.